"Written evidence from Gilead Sciences (LTC 87)&#xa0;Executive summary&#xa0;\n&#xa0;\nIntroduction&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nAgeing and HIV&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nAdherence to treatment&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nConclusion&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nMay 2013\n&#xa0;\n HIV in the United Kingdom: 2010 Report, Health Protection Agency, November 2010\n \nCohen, M., Chen, Y., &amp; McCauley, M. (2011). \nPrevention of HIV-1 infection with early antiretroviral therapy\n. New England Journal of Medicine, 365(6), 493-505.\n Glass, T., \nGeest\n, S. D., &amp; \nHirschel\n, B; \nBattegay\n, M; \nFurrer\n, H, \nCavassini\n, M; \nVernazza\n, P; \nBernasconi\n, E; \nRickenbach\n, M; Weber, R; Bucher, H. S. H. C. S. (2008). \nSelf-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in \nvirologically\n suppressed patients\n. Antiviral Therapy, 13, 77-85.\n \nGazzard, B. G., Anderson, J., Babiker, A., Boffito, M., Brook, G., Brough, G., Churchill, D., et al. (2008). British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV medicine, 9(8), 563-608\n.\n Glass, T., Geest, S.D., &amp;\n&#xa0;\nHirschel,\n&#xa0;\nB; Battegay,\n&#xa0;\nM; Furrer, H,\n&#xa0;\nCavassini, M; Vernazza, P;\n&#xa0;\nBernasconi, E;\n&#xa0;\nRickenbach, M; Weber, R; Bucher,\n&#xa0;\nH.S.H.C.S.(2008). \nSelf-­\n‐\nreported non-­\n‐\nadherence\n&#xa0;\nto antiretroviral\n&#xa0;\ntherapy repeatedly\n&#xa0;\nassessed\n&#xa0;\nby\n&#xa0;\ntwo\n&#xa0;\nquestions\n&#xa0;\npredicts treatment\n&#xa0;\nfailure\n&#xa0;\nin\n&#xa0;\nvirologically\n&#xa0;\nsuppressed patients\n. Antiviral\n&#xa0;\nTherapy,\n&#xa0;\n13,77-­\n‐\n85.\n              \n \nBangsberg\n, D. R., Perry, S., \nCharlebois\n, E. D., Clark, R. a, \nRoberston\n, M., \nZolopa\n, a R., &amp; Moss, a. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (London, England), 15(9), 1181-3.\n \nBangsberg\n, D. R. (2008). \nPreventing HIV antiretroviral resistance through better monitoring of treatment adherence\n. Journal of Infectious Diseases, 197 \nSuppl\n(\nSuppl\n 3), S272-8.\n \nFielden\n, S.J., et al., \nNonadherence\n increases the risk of hospitalisation among HIV-infected antiretroviral naïve patients started on HAART\n, 2008\n \nBangsberg\n, D. R., Perry, S., \nCharlebois\n, E. D., Clark, R. a, \nRoberston\n, M., \nZolopa\n, a R., &amp; Moss, a. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (London, England), 15(9), 1181-3.\n"